# ProShares Ultra Nasdaq Biotechnology (BIB)

Source: https://www.quantisnow.com/company/BIB
Generated: 2026-11-15T12:42:22.388Z

- Type: ETF (exchange-traded fund), not a company
- Ticker: BIB
- Exchange: NASDAQ
- Sector: n/a
- Industry: n/a
- IPO year: n/a

## About

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
 The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

## Latest BIB news and filings

- 2023-02-20 18:14 UTC [Market Insight] [Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine](https://www.quantisnow.com/insight/man-in-germany-cured-of-hiv-after-undergoing-stem-cell-4087364)
- 2021-12-17 16:15 UTC [Market Insight] [Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index](https://www.quantisnow.com/insight/psychedelics-company-compass-pathways-to-join-nasdaq-biotechnology-index-2157450)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BIB
- Earnings history: https://www.quantisnow.com/earnings/BIB
- Dividend history: https://www.quantisnow.com/dividends/BIB
- Insider transactions: https://www.quantisnow.com/insiders/BIB
- Options chain: https://www.quantisnow.com/options/BIB
- SEC 8-K filings only: https://www.quantisnow.com/company/BIB/8-k
- RSS and alerts for BIB: https://www.quantisnow.com/docs/rss-feeds.md